El Nahid Maggie S, Al-Ganiny Amal Fouad Mohamed, Youssef Rasha Nazih
Department of Internal Medicine and Nephrology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
J Diabetes Metab Disord. 2022 Feb 10;21(1):439-444. doi: 10.1007/s40200-022-00990-9. eCollection 2022 Jun.
Engulfment and cell motility 1 (ELMO1), is a candidate gene responsible for cell motility and phagocytosis. However, its role in the development and progression of nephropathy attributed to T2D is still unknown. Kidney injury molecule-1 (KIM-1) plays a significant role in renal regeneration processes. The current study aimed to evaluate the association between kidney injury molecule-1 levels, ELMO1 gene polymorphism (rs741301, and rs1345365) as well as DN in an Egyptian population with T2D.
In this study, we enrolled 89 participants from the internal medicine outpatient clinic, 23 T2DM without DN, 22 with DN, and 44 control subjects. They were genotyped by real-time PCR. Serum level of KIM-1 was detected by ELISA.
Serum KIM-1 level was correlated with DM duration, HbA1C, and UACR (P value <0.001) in T2D. There was no significant difference in the allelic and genotypic frequencies of rs741301 and rs1345365 between participants with DM who presented with albuminuria and those without. Results showed that rs1345365A/rs741301T and rs1345365G/rs741301C haplotypes were more common in patients with T2D than in HCs. However, the difference was not statistically significant (P = 0.262 and 0.414, respectively).
KIM-1 can be a useful non-invasive biomarker for detecting early DN. The association between ELMO1 gene polymorphisms and the risk of DN in patients with T2D was not validated. Therefore, further studies with a larger sample size must be conducted.
吞噬与细胞运动蛋白1(ELMO1)是一种与细胞运动和吞噬作用相关的候选基因。然而,其在2型糖尿病所致肾病发生发展中的作用尚不清楚。肾损伤分子-1(KIM-1)在肾脏再生过程中起重要作用。本研究旨在评估埃及2型糖尿病患者群体中肾损伤分子-1水平、ELMO1基因多态性(rs741301和rs1345365)与糖尿病肾病(DN)之间的关联。
本研究纳入了89名来自内科门诊的参与者,其中23名2型糖尿病无DN患者,22名2型糖尿病合并DN患者,以及44名对照受试者。通过实时聚合酶链反应对他们进行基因分型。采用酶联免疫吸附测定法检测血清KIM-1水平。
在2型糖尿病患者中,血清KIM-1水平与糖尿病病程、糖化血红蛋白(HbA1C)和尿白蛋白肌酐比值(UACR)相关(P值<0.001)。出现蛋白尿的糖尿病患者与未出现蛋白尿的糖尿病患者之间,rs741301和rs1345365的等位基因频率和基因型频率无显著差异。结果显示,rs1345365A/rs741301T和rs1345365G/rs741301C单倍型在2型糖尿病患者中比在健康对照者中更常见。然而,差异无统计学意义(P值分别为0.262和0.414)。
KIM-1可作为检测早期糖尿病肾病的有用非侵入性生物标志物。ELMO1基因多态性与2型糖尿病患者糖尿病肾病风险之间的关联未得到验证。因此,必须进行更大样本量的进一步研究。